相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells
Shaojian Lin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
miR-302a-3p suppresses melanoma cell progression via targeting METTL3
Xiao Chang et al.
JOURNAL OF CHEMOTHERAPY (2022)
The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA
Xiaofeng Yu et al.
MINERVA MEDICA (2022)
Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression
Hao Liu et al.
MOLECULAR CANCER (2022)
METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression
Yu-qing Guo et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)
YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7
Jingnan Pi et al.
CANCER RESEARCH (2021)
Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice
Yue Sheng et al.
BLOOD (2021)
METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway
Xuehan Bi et al.
CANCER GENE THERAPY (2021)
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246
Xuehan Bi et al.
CELL DEATH DISCOVERY (2021)
IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m6A/FOXM1 manner
Fei Ji et al.
CELL DEATH DISCOVERY (2021)
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
Xiangyuan Luo et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)
m6A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer
Lei Xue et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway
Lin Zhang et al.
RNA BIOLOGY (2021)
ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis
Hao Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Oncogenic Role of Long Noncoding RNAMALAT1 in Thyroid Cancer Progression through Regulation of the miR-204/IGF2BP2/m6A-MYC Signaling
Mao Ye et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance
Guangxian Mao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer
Hongyu Wu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma
Lili Hao et al.
AGING-US (2021)
m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells
Liang Hao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
N-6-methyladenosine (m(6)A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability
Han Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Omeprazole improves chemosensitivity of gastric cancer cells by m(6)A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation
Shuitu Feng et al.
BIOSCIENCE REPORTS (2021)
The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma
Jiang Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1
Jun Mao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation
Poshan Yugal Bhattarai et al.
CANCER LETTERS (2021)
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/ VIMENTIN pathway in bladder cancer cells
Ning Zhang et al.
CANCER LETTERS (2021)
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner
Xiaoping Pan et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Ying Qing et al.
MOLECULAR CELL (2021)
METTL3 restrains papillary thyroid cancer neutrophil infiltration
Jing He et al.
MOLECULAR THERAPY (2021)
ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma
Ye Yuan et al.
CELL DEATH & DISEASE (2021)
EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
Runping Fang et al.
NATURE COMMUNICATIONS (2021)
Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression
Ling Wei et al.
HUMAN CELL (2021)
Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11
Zhuoyang Fan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function
Lifang Ma et al.
REDOX BIOLOGY (2021)
YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway
Xudong Shen et al.
FRONTIERS IN GENETICS (2021)
The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells
Aline Kowalski-Chauvel et al.
CANCERS (2021)
N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization
Jiandong Liu et al.
ARCHIVES OF TOXICOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
WTAP facilitates progression of endometrial cancer via CAV-1/NF-κB axis
Qin Li et al.
CELL BIOLOGY INTERNATIONAL (2021)
Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis
Zeyan Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
Pingfu Hou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
Xin Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis
Chenlong Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
IGF2BP3 Expression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma
Akiyuki Wakita et al.
JOURNAL OF SURGICAL RESEARCH (2021)
N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma
Jie Shen et al.
LABORATORY INVESTIGATION (2021)
The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity
Jiadong Liu et al.
NATURE (2021)
Aberrant activation of m6A demethylase FTO renders HIF2αlow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors
Chuanjie Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival
Jiaxun Zhao et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2021)
METTL3-mediatedm6Amodification ofZBTB4mRNA is involved in the smoking-induced EMT in cancer of the lung
Cheng Cheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
PADI2-Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1-Mediated SOX2 mRNA Stability in Endometrial Cancer
Teng Xue et al.
ADVANCED SCIENCE (2021)
Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
Sijin Sun et al.
FRONTIERS IN GENETICS (2021)
Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer
Fangbin Zhang et al.
AGING-US (2021)
Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma
Wei-Lie Mo et al.
Aging-US (2021)
USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization
Lutao Du et al.
CANCER RESEARCH (2021)
Single-nucleotide polymorphism rs4142441 and MYC co-modulated long non-coding RNA OSER1-AS1 suppresses non-small cell lung cancer by sequestering ELAVL1
Weijia Xie et al.
CANCER SCIENCE (2021)
METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
Hui Han et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma
Lifang Ma et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA
Guo-Wei Huang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)
HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA
Fengjie Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
The FTO m6A demethylase inhibits the invasion and migration of prostate cancer cells by regulating total m6A levels
Kai Zhu et al.
LIFE SCIENCES (2021)
ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma
Hui Yu et al.
MAMMALIAN GENOME (2021)
The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis
Mohammad Burhan Uddin et al.
MOLECULAR CANCER (2021)
CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
Fei Xie et al.
MOLECULAR CANCER (2021)
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova et al.
NATURE (2021)
m6A demethylase RD induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer
Yanyun Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2
Haocheng Wang et al.
FRONTIERS IN ONCOLOGY (2021)
METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression
Xiaoting Chen et al.
FRONTIERS IN ONCOLOGY (2021)
被撤回的出版物: miRNA-193a-3p Regulates the AKT2 Pathway to Inhibit the Growth and Promote the Apoptosis of Glioma Cells by Targeting ALKBH5 (Retracted article. See vol. 11, 2021)
Yong Cui et al.
FRONTIERS IN ONCOLOGY (2021)
The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma
Hanfei Chen et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)
AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation
Xinyu Bian et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
N6-methyladenosine (m6A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
Jun Tang et al.
CELL DEATH DISCOVERY (2021)
m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
Dong Xiao et al.
Aging-US (2021)
METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d
Honggui Ma et al.
Aging-US (2021)
A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication
Yue Sheng et al.
BLOOD (2021)
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
Siming Qu et al.
BMC CANCER (2021)
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma
Yu-Zhou Chang et al.
CANCER LETTERS (2021)
M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma
Xinyao Qiu et al.
CANCER RESEARCH (2021)
N6-methyladenosine-Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression
Junge Deng et al.
CANCER RESEARCH (2021)
IGF2BP2 promotes the progression of colorectal cancer through a YAP-dependent mechanism
Jie Cui et al.
CANCER SCIENCE (2021)
CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p
Mingjun Li et al.
CELL CYCLE (2021)
YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect
Yichao Hou et al.
CELL DEATH AND DIFFERENTIATION (2021)
LncRNA MSC-AS1 motivates the development of melanoma by binding to miR-302a-3p and recruiting IGF2BP2 to elevate LEF1 expression
Yan Ma et al.
EXPERIMENTAL DERMATOLOGY (2021)
CCAT2 enhances autophagy-related invasion and metastasis via regulating miR-4496 and ELAVL1 in hepatocellular carcinoma
Jing Shi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis
An Wang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Sipei Nie et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NE-κB and promote the malignant progression of glioma
Rui-Chao Chai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance
Kellie A. Cotter et al.
MOLECULAR CANCER RESEARCH (2021)
ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B
Hongtao Gong et al.
MOLECULAR CARCINOGENESIS (2021)
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer
Jaclyn M. Einstein et al.
MOLECULAR CELL (2021)
Advancing therapy for osteosarcoma
Jonathan Gill et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD
Zhifeng Liu et al.
NEUROCHEMICAL RESEARCH (2021)
N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression
Pengxiang Chen et al.
ONCOGENE (2021)
IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR
Liangpeng Dong et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
IGF2BP1 Promotes the Liver Cancer Stem Cell Phenotype by Regulating MGAT5 mRNA Stability by m6A RNA Methylation
Yichun Yang et al.
STEM CELLS AND DEVELOPMENT (2021)
METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer
Xiaoping Zhang et al.
CELL DEATH & DISEASE (2021)
METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding
Wei Wang et al.
NATURE COMMUNICATIONS (2021)
METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors
Alessia Iaiza et al.
CLINICAL EPIGENETICS (2021)
METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1
Yilong Ai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
被撤回的出版物: m6A demethylase RD suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling (Retracted article)
Juan Zeng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer
Fei Ji et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
Ruyi Li et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
Xiaoying Lou et al.
CELLS (2021)
The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
Qi Yao et al.
FRONTIERS IN ONCOLOGY (2021)
Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis
Xiaodan Wu et al.
FRONTIERS IN ONCOLOGY (2021)
Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer
Libin Jiang et al.
FRONTIERS IN ONCOLOGY (2021)
METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m(6)A Dependent Manner
Jia Shi et al.
FRONTIERS IN ONCOLOGY (2021)
m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer
Congjun Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1
Duo Wang et al.
FRONTIERS IN ONCOLOGY (2021)
HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster
Kexin Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway
Hao Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization
Chuandong Lang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer
Jiaxin Chen et al.
THERANOSTICS (2021)
Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a network
Xinwang Yan et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2021)
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer
Kazuo Tsuchiya et al.
ONCOIMMUNOLOGY (2021)
Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells
Yabing Chen et al.
THERANOSTICS (2021)
Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway
Jin Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin
Yan Wang et al.
BIOENGINEERED (2021)
Longnon-coding RNA BLACAT2 promotes gastric cancer progression via the miR-193b-5p/METTL3 pathway
Hao Hu et al.
JOURNAL OF CANCER (2021)
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
Qing Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Knockdown of RNA N6-methyladenosine methyltransferase METTL3 represses Warburg effect in colorectal cancer via regulating HIF-1α
Zhou Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The role of m6A modification in the biological functions and diseases
Xiulin Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Circular RNA circDLC1 inhibits MMP1-mediated liver cancer via interaction with HuR
Hailing Liu et al.
THERANOSTICS (2021)
IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression
Lin Zhang et al.
THERANOSTICS (2021)
m6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7
Xinxia Wang et al.
AUTOPHAGY (2020)
N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
Hong Wang et al.
GENE (2020)
ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer
Peipei Yang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Qiang Wang et al.
GUT (2020)
LINC00467 promotes cell proliferation and metastasis by binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in hepatocellular carcinoma
Wenjin Jiang et al.
JOURNAL OF GENE MEDICINE (2020)
被撤回的出版物: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing (Retracted article. See vol. 30, pg. 2640, 2022)
Xiaoxiang Chen et al.
MOLECULAR THERAPY (2020)
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
Omprakash Shriwas et al.
APOPTOSIS (2020)
ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia
Yinghui Chao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB
Sasithorn Wanna-udom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The N6-methyladenosine (m6A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma
Alexander Strick et al.
BJU INTERNATIONAL (2020)
ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma
Shuo Chen et al.
CANCER CELL INTERNATIONAL (2020)
High-throughput approaches to profile RNA-protein interactions
Misha Nechay et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
N6-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability
Zhiyuan Zhu et al.
GENE (2020)
METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer
Haiyun Xie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA
Na Luo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer
Ran Miao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
Bo Tang et al.
MOLECULAR CANCER (2020)
METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
Xiao Yang et al.
MOLECULAR CANCER (2020)
m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC
Dan Jin et al.
MOLECULAR CANCER (2020)
N6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription
Jun Liu et al.
SCIENCE (2020)
FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation
Yudi Ding et al.
ONCOTARGETS AND THERAPY (2020)
METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
Dong-Dong Yang et al.
FRONTIERS IN ONCOLOGY (2020)
m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma
Zhian Ling et al.
BIOSCIENCE REPORTS (2020)
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang et al.
CANCER CELL (2020)
Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis
Jiazhen Wang et al.
CELL STEM CELL (2020)
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Chao Shen et al.
CELL STEM CELL (2020)
m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis
Yushi Nagaki et al.
GENES TO CELLS (2020)
Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells
Fanhua Kong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
Prognostic values of YTHDF1 regulated negatively by mir-3436 in Glioma
Chenyang Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma
Boyang Liu et al.
CELL DEATH & DISEASE (2020)
RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner
Xingya Guo et al.
MOLECULAR CANCER (2020)
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang et al.
MOLECULAR CANCER (2020)
ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m(6)A-dependent manner
Xiaolei Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B
Yingying Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
Long non-coding RNA CTBP1-AS2 enhances cervical cancer progression via up-regulation of ZNF217 through sponging miR-3163
Shanshan Yang et al.
CANCER CELL INTERNATIONAL (2020)
A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA
Sara Zaccara et al.
CELL (2020)
METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification
Wei Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling
Huiying Li et al.
FRONTIERS IN ONCOLOGY (2020)
Reduced Expression ofMETTL3Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-MediatedCOL3A1Up-Regulation
Yu Shi et al.
FRONTIERS IN ONCOLOGY (2020)
m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis
Jun-Ju He et al.
FRONTIERS IN ONCOLOGY (2020)
HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
Zhi Yang et al.
Aging-US (2020)
UpregulatedMETTL3in nasopharyngeal carcinoma enhances the motility of cancer cells
Zhi-Feng Liu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer
Xiaoxiang Chen et al.
MOLECULAR CANCER (2020)
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
Yunhao Chen et al.
MOLECULAR CANCER (2020)
N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2
Yuan Li et al.
NATURE GENETICS (2020)
M6A Demethylase FTO Plays a Tumor Suppressor Role in Thyroid Cancer
Run Tian et al.
DNA AND CELL BIOLOGY (2020)
m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway
Han Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer
Wei Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer
Zhou Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Huan-he Ni et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Upregulation of METTL14 mediates the elevation ofPERPmRNA N6adenosine methylation promoting the growth and metastasis of pancreatic cancer
Min Wang et al.
MOLECULAR CANCER (2020)
METTL3 promotes the proliferation and invasion of esophageal cancer cells partly through AKT signaling pathway
Huaying Hou et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
Qianqing Wang et al.
CELL DEATH & DISEASE (2020)
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells
Jie Li et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Downregulation ofm6AreaderYTHDC2promotes tumor progression and predicts poor prognosis in non-small cell lung cancer
Shulei Sun et al.
THORACIC CANCER (2020)
YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
Xiangxiang Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer
Yuanyuan Xu et al.
CANCER COMMUNICATIONS (2020)
YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis
Guoqiang Chang et al.
CANCER CELL (2020)
Endometrial Cancer
Karen H. Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth
Bowen Rong et al.
CELL REPORTS (2020)
METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner
Yuntao Shi et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
Peng-Ju Gong et al.
FRONTIERS IN ONCOLOGY (2020)
Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
Saiyan Bian et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1
Jianying Zhou et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis
Caifeng Yue et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism
Jian Pu et al.
FRONTIERS IN ONCOLOGY (2020)
Head and Neck Cancer
Laura Q. M. Chow
NEW ENGLAND JOURNAL OF MEDICINE (2020)
ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer
Xiaowen Pu et al.
JOURNAL OF CANCER (2020)
Upregulation of miR-324-5p Inhibits Proliferation and Invasion of Colorectal Cancer Cells by Targeting ELAVL1
Chijiang Gu et al.
ONCOLOGY RESEARCH (2019)
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA
Jie Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
Li Zhong et al.
CANCER LETTERS (2019)
The Critical Role of RNA m6A Methylation in Cancer
Qing Lan et al.
CANCER RESEARCH (2019)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression updates through inhibiting BNIP3
Yi Niu et al.
MOLECULAR CANCER (2019)
miR-600 inhibits lung cancer via downregulating the expression of METTL3
Wenwen Wei et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation
Zhenzhen Wang et al.
EBIOMEDICINE (2019)
LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs
Yanshan Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Yue Huang et al.
CANCER CELL (2019)
A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA
Jia He et al.
CANCER LETTERS (2019)
Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression
Jialiang Zhang et al.
NATURE COMMUNICATIONS (2019)
Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma
Zhuo-Xian Rong et al.
FRONTIERS IN ONCOLOGY (2019)
Determination of RNA Hydroxylmethylation in Mammals by Mass Spectrometry Analysis
Xue-Jiao You et al.
ANALYTICAL CHEMISTRY (2019)
FunDMDeep-m6A: identification and prioritization of functional differential m6A methylation genes
Song-Yao Zhang et al.
BIOINFORMATICS (2019)
Deciphering the m6A Code via Antibody-Independent Quantitative Profiling
Miguel Angel Garcia-Campos et al.
CELL (2019)
ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1
Jun Zhang et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
Jie Han et al.
MOLECULAR CANCER (2019)
RNAmod: an integrated system for the annotation of mRNA modifications
Qi Liu et al.
NUCLEIC ACIDS RESEARCH (2019)
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner
Jia-Yi Qian et al.
ONCOGENE (2019)
m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways
Ru Deng et al.
ONCOTARGETS AND THERAPY (2019)
m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Seungwon Yang et al.
NATURE COMMUNICATIONS (2019)
Single-base mapping of m6A by an antibody-independent method
Zhang Zhang et al.
SCIENCE ADVANCES (2019)
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
Yunhao Chen et al.
MOLECULAR CANCER (2019)
The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion
Tianfang Xia et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells
Hai-Lan Yu et al.
ONCOTARGETS AND THERAPY (2019)
MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62
Huabo He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The interplay between m6A RNA methylation and noncoding RNA in cancer
Shuai Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
Ben Yue et al.
MOLECULAR CANCER (2019)
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
Wen Ni et al.
MOLECULAR CANCER (2019)
Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1
Chaohui Gu et al.
MOLECULAR CANCER (2019)
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
Jiajie Hou et al.
MOLECULAR CANCER (2019)
RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway
Jiarong Cai et al.
ONCOTARGETS AND THERAPY (2019)
被撤回的出版物: MicroRNA-139-3p Inhibits The Growth And Metastasis Of Ovarian Cancer By Inhibiting ELAVL1 (Retracted article. See vol. 15, pg. 839, 2022)
Fang Xue et al.
ONCOTARGETS AND THERAPY (2019)
Accurate detection of m6A RNA modifications in native RNA sequences
Huanle Liu et al.
NATURE COMMUNICATIONS (2019)
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Yulin Shi et al.
NATURE COMMUNICATIONS (2019)
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
Yue Li et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
Dongling Zou et al.
CANCER CELL INTERNATIONAL (2019)
N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis
Changshui Zhuang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras-ERK signaling
Dehua Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
Maosheng Cheng et al.
ONCOGENE (2019)
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
Tian Lan et al.
MOLECULAR CANCER (2019)
HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A
Daniel Andrade et al.
CANCERS (2019)
m(6)A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression
Jiqin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g
Xiaoli Cai et al.
CANCER LETTERS (2018)
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
Ying Yang et al.
CELL RESEARCH (2018)
ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation
Yuan He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
Mengnuo Chen et al.
HEPATOLOGY (2018)
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting -catenin through mRNA demethylation
Shun Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal
Jing Wen et al.
MOLECULAR CELL (2018)
Recognition of RNA N6- methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huilin Huang et al.
NATURE CELL BIOLOGY (2018)
N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential
Dandan Yang et al.
NUCLEIC ACIDS RESEARCH (2018)
Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of m6A mRNA Methylation
Xiang Zhong et al.
CELL REPORTS (2018)
METTL14 Suppresses the Metastatic Potential of Hepatocellular Carcinoma by Modulating N6-Methyladenosine- Dependent Primary MicroRNA Processing
Jin-Zhao Ma et al.
HEPATOLOGY (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer
Federica Panebianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
YTHDC1 mediates nuclear export of N6 - methyladenosine methylated mRNAs
Ian A. Roundtree et al.
ELIFE (2017)
Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis
Phillip J. Hsu et al.
CELL RESEARCH (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention
Kathryn E. Pendleton et al.
CELL (2017)
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
Sicong Zhang et al.
CANCER CELL (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis
Jingwan Zhang et al.
GUT (2016)
Cytoplasmic Accumulation of ELAVL1 Is an Independent Predictor of Biochemical Recurrence Associated With Genomic Instability in Prostate Cancer
Nathaniel Melling et al.
PROSTATE (2016)
GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression
Xingkang Jiang et al.
CELLULAR SIGNALLING (2016)
Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth
Injie Omar Fawzy et al.
GROWTH FACTORS (2016)
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Wen Xiao et al.
MOLECULAR CELL (2016)
m6A modulates neuronal functions and sex determination in Drosophila
Tina Lence et al.
NATURE (2016)
m6A RNA methylation promotes XIST-mediated transcriptional repression
Deepak P. Patil et al.
NATURE (2016)
m6A-LAIC-seq reveals the census and complexity of the m6A epitranscriptome
Benoit Molinie et al.
NATURE METHODS (2016)
Sleep deprivation and false confessions
Steven J. Frenda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
Ahmad Barghash et al.
ONCOTARGET (2016)
MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis
Yanlin Su et al.
ONCOTARGET (2016)
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217-and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
Chuanzhao Zhang et al.
ONCOTARGET (2016)
5′ UTR m6A Promotes Cap-Independent Translation
Kate D. Meyer et al.
CELL (2015)
A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation
Shengdong Ke et al.
GENES & DEVELOPMENT (2015)
MicroRNA-873 (MiRNA-873) Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1
Ren-jie Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome
Bastian Linder et al.
NATURE METHODS (2015)
Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity
Xintian You et al.
NATURE NEUROSCIENCE (2015)
HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression
S-D Chou et al.
ONCOGENE (2015)
IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1
M. D. Faye et al.
ONCOGENE (2015)
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is an Important Protumorigenic Factor in Hepatocellular Carcinoma
Tony Gutschner et al.
HEPATOLOGY (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Jianzhao Liu et al.
NATURE CHEMICAL BIOLOGY (2014)
The bigger picture of FTO-the first GWAS-identified obesity gene
Ruth J. F. Loos et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian Clock
Jean-Michel Fustin et al.
CELL (2013)
Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA
Nian Liu et al.
RNA (2013)
Leukaemia update. Part 1: diagnosis and management
Nicholas F. Grigoropoulos et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
Pearlly Yan et al.
BLOOD (2012)
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
Mohammed Tanjimur Rahman et al.
CANCER (2012)
ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial-Mesenchymal Transition and Invasion
Julie A. Vendrell et al.
CANCER RESEARCH (2012)
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Kate D. Meyer et al.
CELL (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression
Laurie E. Littlepage et al.
CANCER DISCOVERY (2012)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
David F. Schaeffer et al.
BMC CANCER (2010)
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
Aurelie Thollet et al.
MOLECULAR CANCER (2010)
Identification of a target RNA motif for RNA-binding protein HuR
IL de Silanes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The candidate oncogene ZNF217 is frequently amplified in colon cancer
PH Rooney et al.
JOURNAL OF PATHOLOGY (2004)